Apigenin inhibits lipid metabolism of hepatocellular carcinoma cells by targeting the histone demethylase KDM1A
Cheng Peng(Shandong First Medical University), Shunqin Zhu(Southwest University), Ting Hu(Sichuan University), Ni‐Ni Zhou(Southwest University), Hongjuan Cui(Southwest University), T Chen(Army Medical University), Yan Liu(Zhejiang University), Ximei Zhang(Southwest University), Yang Shen(Jiangnan University)
Cited by 14
Related Papers
Targeting cancer stem cell pathways for cancer therapy
|Signal Transduction and Targeted Therapy|2020|1.9k
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
|Chemical Society Reviews|2021|402
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
|Signal Transduction and Targeted Therapy|2023|364